title: Drug interactions in HIV-positive patients initiated on protease inhibitor therapy.
authors.forename: S L
authors.initials: SL
authors.lastname: Preston
authors.forename: M
authors.initials: M
authors.lastname: Postelnick
authors.forename: B D
authors.initials: BD
authors.lastname: Purdy
authors.forename: J
authors.initials: J
authors.lastname: Petrolati
authors.forename: H
authors.initials: H
authors.lastname: Aasi
authors.forename: D S
authors.initials: DS
authors.lastname: Stein
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D017291:Clarithromycin / Q000009:adverse effects; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D011480:Protease Inhibitors / Q000009:adverse effects*; D017828:Rifabutin / Q000009:adverse effects
chemical_list: D019380:Anti-HIV Agents; D000929:Antidepressive Agents, Tricyclic; D011480:Protease Inhibitors; D001569:Benzodiazepines; D017828:Rifabutin; D017291:Clarithromycin